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Although shown to be highly expressed by the epi~ 
dennis in inflammatory skin disease, the ability of the 
Fas protein to trigger apoptosis in the distinct cell 
subpopulations of cutaneous tissue, particularly with 
regard to receptor density and the degree of cross~ 
linking, has not been fully characterized. We there~ 
fore determined the effect of Fas cross-linking in 
prhnary human dermal fibroblasts at both high and 
low levels ofFas receptor expression. First, we exam-
ined the effects of the anti~Fas monoclonal antibody, 
CH-l1, on fibroblasts expressing low basal levels of 
Fas. In these cells Fas aggregation stimulated prolif-
eration by 160 ± 10% over untreated controls. In 
contrast, the same concentration of CH-l1 had an 
inhibitory effect on epidermal keratinocyte growth. 
Because Fas is upregulated in inflamed skin, we next 
C ontinunl pressure frOI11 environmell.tal still1 ulj re-quires that mammalian skin possess all array of pote nt genetic programs mediating a range of tissue responses. In many cases the activation of such programs arc triggered by cell surface receptors. 
Tumor necrosis factor receptors (TNFR) comprise a multi-gene 
family that exerts profound effects in skin as well as other tissues, 
and TNFR f."nily signaling e!tects may differ by target ce ll and dose 
of cognate ligand. TNFR. signal transduction is activated by 
oligomerization of receptor cytophlsmic domains induced by extra-
cellular binding of ligand (Heldin, 1995). Fas is a TNFR fal1lily 
protein and cross-linking of cell surf~lCe Fas hy Iymph ocyt l'-
expressed Fas ligand (Sud;1 1'1 nl. 1993) can initiate a form of ce ll 
deadl known as apoptosis. Apoptosis ca n he triggered by Fas as well 
as by a variety of other stimuli that illc lude la ck of growth factor 
stinlulation nnd extracellular matrix detachment (Clevelalld and 
lble, 1995) . Apoptosis involves distinct IIlh'as tru c tural and lIIol ec-
ular alterations including chromatin condensation. DNA fragmen-
tation, and cellular shrinkage and collapse. TNFR. talllily receptors 
may produce different cellular e!teets ill response to varying mag-
nitudes of receptor expressioll and trigg ·ring by cognate ligand . For 
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examined the effects of Fas cross-linking on fibro-
blasts expressing augmented levels ofFas. Fibroblasts 
were either transfected with plasmids for overexpres-
sion of full length or bioengineered Fas receptors or 
were transduced with a retroviral Fas expression 
vector. In these cells Fas oligomerization triggered 
the morphologic changes indicative of apoptosis re-
gardless of whether or not the Fas-signaling domain 
was tethered to the plasma membrane. These studies 
indicate that Fas oligomerization in dennal fibro-
blasts may initiate dual signaling programs, either 
proliferation or apoptosis, and that the chosen out-
come may depend upon the magnitude of Fas aggre-
gation. Key lVords: sigllal trallsdllctiol/lge"e expressio,,1 
TNFRfartlilJI. ] I"vest Dermatol 108:215-219, 1997 
example. effects ranging &0111 cellular proliferation to metabolic 
alterations and ce llular lysis may be produced by differenr strengths 
of TNF(l'-l11ediat 'd sigllal transduction (Smith el al. 1994). and Fas 
signal transmission does nOt initiate apoptosis under all conditions 
(Suda. cf nl. 1993). 
Dermal fibroblast apoptosis may be triggered in cutaneous 
inflammation and wound remodeling, but a role for Fas in mcdi-
ati ng these processes has not been established (Haake and Pola-
kowska, 199J). FibroblaHs nnd keratinocytes both come into close 
contact with infiltrating Fns ligand-bearing lymphoid cells in COIl-
ditions of cutaneous infection and inflammation. Expres. ed at low 
levels in normal skin. Fas cxpression in epidemlis has he en reported 
to be augmented ill a number of human inR'1111 111 a tory and infec-
tious skin disenses (Sayal11a CI 111. 1994) . Fas has been shown to 
triggl'r apoptosi< in IllIm:tn keralinoc)'tes (Sayama ct nl. 1994, 
Freiberg CI nl. 1996). but its effects on underlying dcnllal fibroblasts 
have not bcen tboroughly studied. TNF(y eXl'Tts a growth-stimu-
latory e!tcct on dermal fibroblasts. and. recently. treatment of 
fibroblasts expressing low hasa l levels of cell surffJce Fas with the 
Fas cross-linking tllltibody, CI-I- Il. hOI been shown to exert a 
si milar stim ulatory ctfect ill lIilro (AggarwalI'I til, 1995). Whether 
F'ls is capable of triggering apoptosis in dermal tibroblasts is yet to 
be firm.1 establislKd . Although TNFRs exert effect's th:tt differ by 
t~rget ce ll and liga nd dose. <I potential disparity of Fas effec ts in 
di!tcrent ce ll populations in the <kin. a< well a biologic differences 
du' to magllitucie of receptor activation. arc aho not fully charac-
terized . Here we prcscllt data indicatillg that Fas triggering may 
sti lllul:tte both fibroblast proliferation. as well ns apoptosis, and that 
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Figure 1. Expression of wild type Fas in normal human fibroblasts: basal levels and overexpression itl vitro. (a) Norma l humall fibroblasts w 
either un treated or (b) transfe.cted with a fulileng~h Fas expression plasmid and subjccte? to imll~ulloflu orcscence ~t:l il1il1 ~ wi~h . the ~H- I I Pas rnonoclo~:~ 
anobody. Tral~sfcctlOn to acluevc Fas overexpressJOn In 5-15% of cells was performed uSIng JIl od lficdyolybl:cllc sho~k: (e) S la~nlll g Wllh second"ry an tibody 
alo ne was utilized as a control for background immunoflu orcscence and (d,e,!) slides werC countersla med wJth propldllllll Iod Ide to iden tify all ce ll s presel;t 
as shown above. Scale bar. 10 !J.m. 
the d eciding factor b etween these two o u tcomes appears to b e the 
mag nitude of Fas expression. 
MATER1ALS AND METHODS 
Cell Harvesting and Tissue Culture Primary human fibroblast.~ were 
isohlted from neonata l foreskin and adu lt skin biops ies . as prev io usly 
described (Balear ,.( al. 1994). Fibroblasts were cultured in growth mcdia 
consisting of 90% Dulbecco's ModifIed Eagle Mediulll (DMEM: G IBCO. 
Grand Island , NY). 10% Bovine Calf Serum (BCS; H yClo ne. Logan. UT). 
penicillin-strepromycin. 100 units pcr 1111 (GrBCO). Cells were incubated at 
37°C in all atmosphcre of 5% COz!95'Y. air. 
Immunofluorescence Earl y passage (passage 1 or 2) transfected and 
nontrans!ccted no rmal hUlnan fibroblasts were grown on glass slides to 
30-60% confluence . Ccll s or tissue sections were fixed with icc-cold 
acetone. thcn blocked with 10% horse serum in phosphate buffered saline 
for 1 h . Slides were srained with the C H-ll m onoclonal antibod y to human 
Fas (Yonehara el al. 1989) at lOng pcr ml and subjected to immunofluo-
rescence analysis. Contro l slides incubated w ith secondary flu oroscein 
isothiocyanatc-labeled an.ti-mo use antibody (Sigma C hem ical Co. St. Louis. 
MO) alone were used as a measure of backgrou nd no nspecific fluorescence. 
All slides were counterstained with propidiuln iodide. 
Gene Transfection and Retroviral Transduction Primary fibroblasts 
were cultured in 35-mm plates to 75% confluency and transfectcd in 
triplicate fo r all transfections by modified polybrene shock Oiang el ai , 
199 I). The myristyla tcd and nunmyristylated PKS06 binding protein 
(FKBP) and Fas-FKBP expression constructs in the pEJ5 eukaryotic expres-
sion plasmid (Takcbe el al. 1988) included Pas amino acids 179-319 linked 
to three t OS- amino acid FKBP domains and the HA epitope tag (Spencer 1'1 
al. 1996). Briefly, 760 !J.I of growth m edium were mixed with plasm ids and 
vortexed vigorous ly. I-Iexadimcthcrinc bromide (3 .8 !J.I at a concentration 
of 1 mg per ml) (po lybrene, Aldrich C hemical C o .. Milwaukee. WI) in 
phosphate buffered sa line was thell added. T he mixture was vortexed and 
overl ayed o n the ce lls for 6 h . After aspi ratio n of the polybrenc mix ture . 
28% dimethylsu lfoxide (Sigma) in growth medium was applied to the cell s 
for 90 s. then aspirated , and the plates were rinsed twice with phosphate-
buffered saline!l 0% ca lf serum; lTesh growth medium was then added. and 
the ce lls were incubated overnight at 3rC prior to add ition of FK1 012 at 
100 nM or C H-l I antibod), at 1 !J.g per ml. An amphotropic retrovirus 
designed to transcribe full length wild type hum'1I1 Fas off the rctroviral long 
tenninal repeat was produced and used to transduce pri mary human 
fibroblasts . This construct was produced by subclonin g the full open reading 
frame ofh uJ11an Fas (ltoh el nl. 1991) , minus 5'- and 3' -cDNA sequences 
into the EroRI si te of the LZRS retroviral cxpressio n plasmid (Kinsella and 
Nolal.l. 1996).: infcctious amphotropic retrovirlls \~ ;lS prod uced as previousl\' 
descnbed (Kinsdla and Nolan , I 99(,). Unet1~. hb~(lhla s t· s were grown t~ 
20%, confluencc 111 35-1I11Tl plates and overl a~d w ith 1.5 1111 of rctroviral 
supernata nt WIth po lybrenc at 5 !J.I' per 1111. After centl-iful'a tio n at 300 X 
fo r l h. cell s were incuba tcd al 37"C f~r 6 h and ~ i ven li'c,h 'llcdillm . Fo~ 
eight ho urs later, cells were treatc.d WIth C H- I I al I !J.I' per ml or diluel;t 
. Ione and anal yzed for I110rpho iogIC changes by phase contrast microscopy. 
CeU Staining and Mo,rphologic Grading A cytomega lovirus promot-
er-dri ven i3-galactosidasc was u<cd as a CO- lTaIlSfcCled marker gene t 
identi ty transfected cel ls. Eight hOllrs after addition of 100 11M FKI () I 2 Or ~ 
lJ.,g C H- t I per ml. fib ro b]"sts were <lained lItilizillg X-ga l and cells 
examined via phase contrasl micro< 01')'. Ce ll s that were shnll1ke 
ro unded, and displayed bleb fo rmalion :It rheir periphery werc scored : : 
apoptotic. as previously desc ribed (Chilln"iy"" d al. 19\15: Sta nger e, at 
1995) , while cell s retaining normal 'te ll a t.e fi bro hlast Illo rpho logy wcrl: 
graded as nonllal. TOT- mediated dUTI'- biolin nick end- labeling W<lS 
pcrformed usi ng d igoxygenin-conj ugaled dUTP fo llowed by sta ining with 
a flu o rescein-linked alltibody to digoxygc llin (ApoI'Tag. O llcor. Gaithers_ 
burg. MD) (Teramoto ('I al. 1995) a.lld vi,ua li za lion hy flu orescence 
microscopy. 
RESULTS 
Basal and Augmented Levels of Fas Expression in Normal 
Human Fibroblasts Because Fas expr 'ss io n is dramatica ll y up-
regulated in a numbe~ of human skin d.iseases( ayama el ai, 1994) . 
we wanted to determll1c whether Fas slg ll a l transduction effects in 
skin fibroblasts were influenced by different magnitudes of Fa 
expression and o ligomerizati In . TNFO' ca n se rve as a fibrobl ast 
mitogen, and it has recently been reported tha t additioll of Fas 
cross- linking antibody to fibroblasts express ing lo w con stitutive 
le vels of cell surface Fas a lso ,til11ul ates proliferation (Aggarwal el 
ai, '1995). Untransfected cells displayed low, bu t detectable. levels 
of Fas expression above n o n specific background flu o resccnce (Fig 
1a), in agreem e nt with a recent stud y u si n g f1u o resccnt activated 
cell sorting (Aggarwal 1'1 111. J 995). In order to romparc effects of 
Fas sig n a l transduction at low and hi gh magnitudes of Fas expres-
sion and o li gom erization, we then overexpressed Pas ill n ormal 
fIbro bl asts via transient transfi'ctioll of all expression plasmid for full 
leng th humaJ1 Fas. Fibrob lasts transfected by this appro~ch ex-
pressed sig nifi cantl y more Fas than b<lsa l levels. as d etected bv 
immunofluo rescence stainin g; a cl uster of positive cell s is show~ 
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Figure 2. Fas cross-linking induces opposite effects on prolifera-
tion o£ fibroblasts and keratinocytes al low basal levels of Pa. 
expression. Primary h'''I1"n skin lihr"hl"sl, or kcralinocytc< (~O.IlOO) were 
plated in 35-nllll wells. Cell, were growII ill Ihe prest'lIce 1 1- 1 or "bsence 1 1 
ofCH-1 I Fas ",olorinl,,1 anrihody.1I I J.Lg per 1111 t,", ~H 1. aud trypsilli zed. 
and viable cells wcre COllllll'd by Iryp:lll blul.' l'xci u .; ion. Bt1~dillC' IlUlllher of 
cells was 363,.1.13 f," ' tihrobla,t\ and 520.01l0 Ii.lr kl' ralillo<') tes; d.,ta are 
expressed as .. SEM . 
with an adjacellt untTansfected ce ll in Fig 1 II. Thest· findings 
provided an oppoi'lunity to examille efieTts of Fas triggering in 
fibroblasts at higher levels of Fas expres~ioll . 
Fas Oligomerization Triggers Morphologic Changes of Ap-
optosis in Fibroblasts Only at Higher Levels of Protein 
Expression Next. we determined the efl~cts of Fas triggerillg in 
nonnal skin fib1'Obiasts at low alld high levels of Fas expl·essioll. 
First. we confirmed the milogenic effcct' of Fas oligol1lerization ill 
non11al humall ribr()hhl~t~ at low level, of l'onstituitive Fas expres-
sion; additioll of the Pas cnHs-lillkillg antibody CII-I I at I ILg pt'r 
ml induced a 160 1. I O'X, prolitcration of fibroblaHs over untreated 
cells during a 48-11 till1ecourse. This was ill marked cOlltrast to 
results obtained ill keratilloc),lt's, which numbered ollly !!J :t 9% of 
untreated control over the sal1le tillle period (Fig 2) . These data 
confirm that fibroblasts. uJllike epidel'lllul keratillocytes. react to 
low levels of Fa~ cross-lillkillg by proliferatioJl (Aggarwa l ('I (/1. 
1995). Then we IItilized fuiliellgth wild type Fas and FKBP-lillked 
Fas to exal1line Fas fUllction in libroblasts at higher levels uf Fas 
protein expression. TN FR filillily rec 'ptor sigllal transduction is 
triggered by receptor oligol1lerizatioll and. although alltibodies 10 
cell surface receptors have beell ,uccessfully USed to trigger specific 
rignaJ transduction pathways. the efftciency of this approach rna)' 
vary with the specific alltihody utili7cd and with the density of cell 
surface reccptor expression (Merino 1'1 (/1. 1995). As an additional 
control for the 1-1- 11 Fas cross- linking mOlloclollal antibody. 
therefore, wc used the FK 101 2 oligol\lcrizillg agent (Spencer 1'1 (/1. 
1993) and FKIO 12-0 ligomerized engineered Fas. FKI () 12 is a 
di01eric form of thc lI1~crolide FK5()6. which lacks any iml11uno-
suppressant effects and can oligomerize any IWO proteins engi-
neered to contain th' 105-ami1lO acid FK506 bindjng protein 
(FKB P) (Spencer et nl. 1993). o-trallStcction of the f3-galartosi-
dase (,B-gal) genc has been uscd as a marker of cellular transfcction 
(Chinna iyaJ1 cl rlf, 1995; Stanger 1'1 nl, 1995) . Trallsfcction of normal 
fibroblasts with a ytol11cgalovirus {3-gal reporter plasmid alone 
produced a low proportion «5"/0.) of cells with morphologic 
changes of ce ll shl'i nkage and roullding secil ill apopto,is. p()s~ihly 
due to the impact of the lramtC:ctioll proced urc itself. At the low 
constitutive levels of Fas eXl'rc~sioll SCl'1I ill the\c cells. 11- 1 I at I 
p.g per 1111 failed to substantially incrcasl' the proportion or fibro-
blasts displa)' i.l1g the apoptoti morpholog (Fig 3a). Transfel'ted 
fibrob last · expressing higher Ie cis of ei lher ful l length Fas rail 
FK10 12-responsive ellgim'l'n:d Fas. howl·ver. ullderwent 1I10rpho-
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\\,1I1l "a\ l~ l'lI'tl\'1r:1I 
F'PI\ ,"'Il\/l Vl't:lOI 
l I1llall ... dlll .. ·I..~d 
I lhlohLI' .. h 
e 
I'.os SI(;NAUNC IN FIBROIILASTS 217 
+ CII, I I . CH·II 
Figure 3. Oligomerization of enginccred aJ1d wild type Fa. trig-
gers morphologic changes ofal'optosis in fibroblasts. Normal human 
libn .. bl,,\ts were cotr"",tcctcd with 'ither FK.llP-linked engineered Fas or 
lidl length wild t)'PC Fa, expression plasmid, along with a C)'tomega IO\'i-
r",-{3 galaclosiel,l'" f'\'p"rtcr plasmid. CeI " were trcared ,,;th either FK 11112 
'I t Ion nM. anti-Fa, antibody C H- II at I /ltJ. per ml. or diluent control. 
Eight hOllr, :1ft .... addilion of FK 11112 or antihody. ce ll, were fixed and 
"ained for {:l-galactosidase exprc'sion to highlight tran,fected n(lrmal "rrsrlS 
apol'totic cd l Illorphology. Repre,enlative normal (n) and apoptotic (h) 
fihmhla'is :lrc shown above. SfnlC' 1101', 5 f.L1l1. C"lIs were transfecll·d with 
I"KIlP-linked engineered Fas ,mel ,reated with either lOll nM FK IU12 (f) or 
eliluenl (d) and analyzed for DNA strand hreaks "i" TDT-med.ialed dUTP-
bioI in nick cnd-Iabding. (f) Normal hUI11"" fibroblasts were eillll'r un-
ll'catcd or trall sduccn with :I '"(> trovir::ll vt'ctor for CXprt: SS101l or th~ full 
"'nglh wild I)'pe human Fas prOlein . Cdls were Ihen either incuhated in 
nll'dillln aloll" or medium plu' the 11-1 I Fos cmss-linking antihody '" I Ilg 
per ml. Cd lular morphologic change> of apoptosi< Were analyzed hy pha'!' 
contra'il l1li ('ro~copy . SI"(1/(' I",,., 20 IlIH . 
logic challges of apoptmis in response to thl'ir corresponding 
oligol11erizing stimuli. C H- I I at I J.Lg per ml or 100 nM FK I () 12. 
respectivel),. ill significam numbers of 50% or greater (Fig 3b). The 
prcsence of I NA stnmd breaks in triggered cclls recciving engi-
neered l~ as. but not in ul1triggered controls. was confirmed by 
TDT-mediated dUTP-biotin nick end-labeling; cells demonstrating 
evidellt'e or DNA strand breakage showed positive taining \ hen 
viewed by fluorescence microscopy (Fig 3c) (Teramoto 1'1 (//. 1995) . 
In order to exclude potential confounding variable associated with 
low efF'ciency gene tran, fl'r via episomal plasmids. we included a 
high et!iciellcy. integrating gelle trans("r approach using an ampho-
tropic retroviral expression vector for full Icngth wild type Fas. 
Fibroblasts transduced al high efficiency with this ve ' tor and treated 
with CII-II ilt I J.Lg per 1111 diplaycd widespread morphologic 
ch.lIlges of apoptosis wlll'rcas Fas-overcxpres~ing f,broblasts un-
In'ated with CI-I-Il along with ulltransdu ced tibrohlasts did tlor. 
ont'irmillg thl' capabilil)' of overe~pressed Fas to trigger apoptosi. 
(Fig 3e) . Thcse data suggest that Fas is capable of trig-gcring both 
218 FRErBERG ET ilL THE J URNAL OF INVESTIGATIVE DER."A . .t 
'v, TOLOG~ 
a 
fKJOJ2 MyriJlyhllion I lag 3 PKBP WijdlypoF .. Figure 4. Effects of subcellular localization on Fas signal transduction in fibroblasts . (a) Nonnal fibroblasts were trans-
fected with FKBP-linked Fas proteins containing either the wild 
type Fas cytoplasmic domain with the myristylation tag from v-src 
for membrane localization or with the wild type Fas cytoplasmic 
domain with no membrane localization signal. Sixteen hours after 
addition of FK1012 or antibody, cell s were fixed and stained for 
j3-galactosidase expression. Scale bar, 5 fLlTl. Laser confocal immu-
nofluorescence microscopy was used to examine the subcellular 
10calizatiol1 of either un tagged engineered or myristylation-tagged 
Fas in transfected fibroblasts using the 12CAS antibody to the HA 
epitope on the carboxy tenninus of these proteins. (b) Engineered 
Fas lacking the myristylation sequence appeared diffusely within the 
cell willie (c) rhe myristylation-tagged engineered Fas localized 
primarily to the cell perimeter. Scale bar,S fJ.m. 
Plasma Membrane 
~"A+ DomainIJ p .. 
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proliferation and apoptosis in fibroblasts and that the outcome of 
Fas signal transduction in these cells may depend on the magnitude 
of Fas expression and oligomerization. 
Localization ofFas Oligomerization Away from the Plasma 
Membrane Fails to Abolish FAS Signal Transduction in 
Fibroblasts Major cell surface receptor £1milies flUlction via cell 
membrane-linked effector proteins; however, recently identified 
mediators of Fas signal transmission appear to lack obvious features 
suggesting plasma membrane restriction (Chinnaiyan e/ ai, 1995; 
Sato et nl, 1995: Stanger et ai, 1995). To probe for the existence of 
potential plasma membrane localization requirements for the initi-
ation of Pas signal transduction in fibroblasts , we transfected 
fibroblasts with the cytoplasmic domain of Pas linked to FKBP, 
either with or without a membrane-locaIizing myristylation tag. 
Non-membrane-targeted engineered Fas was active in fibroblasts 
but displayed higher background levels of apoptotic cells than the 
membrane-targeted protein and lower maximal levels of effective-
ness, as well (Fig 4a). Laser confocal immunofluorescence micros-
copy was then used to confu:m the subcellular distribution pattem 
of the active myristylation-tagged and un tagged Fas hybrids. T he 
un tagged conStruct appeared diffusely within the cell whil e the 
tagged construct was mainly loc;llized to the fibroblast cell perim-
eter (Fig 4b,c), suggesting that certain features of the initiation of 
Fas signa.1 transduction may not require strict plasma membrane 
10ca1.ization. This finding suggests that, although Fas may trigger 
apoptosis when localized away from the plasma membra ne in 
fibroblasts, it may be less specific and effective there than when it is 
anchored in the plasma membnlJ1c. 
Increased Dennal Fas Expression in Inflamed Skin An 
increase in epiderm al Fas expression has been reponed in inflam-
matory skin diseas(, (Sayama ef ai, 1994), and we wished to 
detennine whether cells in the dermis also upregulatcd Fas in this 
setting. lmmunostaining of normal human skin (Fig Sa), as well as 
skin affected by an inflammatory skin process, i.e. , a drug hyper-
sensitivity eruption (Fig Sb), was performed using antibody to the 
human Fas protein , along with doublc staining with propidium 
iodide to highlight cellular nucle i (Fig Sc,d). Cells in the inflamed 
dermis demonstrated a marked increase in Fas staining . Although 
identity of specific cells was not clear in all cases, iJJcreased Pas 
expression by cel ls with spindle-shaped nuclei is consistent with an 
upregulation of fibroblast Fas expression in this setting. 
DISCUSSION 
Although apoptosis has been postulated as important in a range of 
cutaneous processes, such as inflammation and wound remodeling, 
o 20 40 60 80 100 
% Apoptotic Fibroblasts 
the ro le of Fas in triggering this proces~ in response to lymph 
. . d · fi ocytes 
express1l1g the Fas ligan IS not ·ully ch<lracterizcd. Fas . 
. . . . SIgna.] transdllc~lOn appears to tngger apoptoslS III keratinocytes of the 
outcr epldel·~nal lay.er, whether F<lS IS expressed at low or high 
levels. It IS IIlterestmg to speculate that Fas sigl1'lling t' ll d 
• • ". < ermal fibroblasts may possess add Itional versatility In recognizing diffi . 
f . , T I . erulg strengths 0 receptor tngger~llg. 1C stll11u lus to fibrob last prolif. 
eration il1itiat~d by a?greg~tlon ~f. Fas at l o\~ levels of expre sioll. 
suggests that mtcractlon With Fas bgalld-bc3nng lymphoid cells' 
this setting may pro~note the prol.iferatiol~ .of ~lbroblasts necessa~ 
for the wound-healmg response III cond itIOns of mild Cllt3l1COll'S 
Figure 5. Fas expression on fibroblasts in normal and diseased 
human skill III 1';110. ((/) ImllluIIOHuorc\cc ll c(' ~1I~ l ysis was performed using 
Cl-I-l I .,ui-Fas antibody on skin biop'y 'pccimcns obtained frol11 a 110rmal 
patient and (b) from lesion skill of a paticllt with all allergic drug eruption. 
(c,d) Propiduim iodide was lIsed to counterstain the nuclei of all the cells. 
Scale /Jar, 50 Ikm. 
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inju ry. Fas e xpressio n may be upregul ated in cell s of the 'ki ll both 
ill lI it ro in response to interfe ro n-y and ill "illo in inA ammatory and 
infectious skin d isease (Saya m3 cl II I. 1994). In se vere infections and 
inflamm atory pmcesses, uprcgul ation of cell slIrf.'1ce Fas expression 
may rende r the encountcr with a Fas ligand-expressing lymph ocyte 
le thal ; th c ad van t~ge of <uch a response wo uld be clea r in situ~ ti ons 
of tissue necrosis and ce lllt!;, r pa rasiti sm by micro bes, w here rapid 
elimination of dam aged fi bl'oh lasts would be vi ta l in debridin g the 
skin and in ti ss ue repai r . Fas-overexpressing tibrobl asts in th is 
setting wo uld thus presen t in fi ltra ting T lymp hocytes wi th a rapid 
mech anism to e ljrninate suspect ce lls in th e de rmi s. Mcch;l11isticall y. 
the expl an atio n fo r different effects via Fas o ligom erizatio n at low 
and higb levels of Fas express ion ma y be du e to altered interact.ions 
with molecules downstrea m ofFas o ligo me ri zation that aftec t signal 
transdu ctio n ou tcom es, such as 13('1-2 t;lmil y proteins and ill te rl eu-
kin 1-converting en7yme. A !lumber of downstream effectors ofFas 
signal transdu ction h ave been recentl y iden titied (Chinn aiyan cl II I. 
1995 ; Sato CI aI, 1995; Sta nge r el aI, (995). U nlik e many o th er 
receptor fami ly effenors. 1l 0lle of these displ ay o bvi ous plasma 
membrane restrictio n; this is consistcnt with our ~ind i ng rllar 
oligom erization of FOlS in tlte cyto pl asm ini tiates changes of apo-
ptosis in fi broblasts. 
In summary, o ur data in d icate tha t Fas o ligom crization in normal 
human fibrob las ts may activate dual programs fo r either cellular 
proliferati on or apoptosis ;lI1d that the distinguishing facto r be tween 
these two o utcomes may be tlt e m agni tude o r Fas ex pres ' io n and 
aggrega tion. T hese find in gs sugges t a potential m echanism to r 
immune ceil modul atio n o r cOlllpl ex genetic programs expresseci by 
fib ro blas ts in the skin and offer a mechani sm fo r cx panded versa-
tility in receptor signalin g. 
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